Praxis Precision Medicines, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2026.

Symbol
PRAX on Nasdaq
Location
Boston, MA
Fiscal year end
31 December
Latest financial report
19 Feb 2026

Latest SEC snapshot (2026-02-16) highlights Return On Equity -45.8%, Return On Assets -42.7%, and Current Ratio 10.22x.

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

4.1/100

Weak Confidence medium

Return On Equity

-46%

Metric score 0.0/100

Return On Assets

-43%

Metric score 0.0/100

Financial Health

Current Ratio
10.22x

Strengths

No strong signals yet.

Watchpoints

Return On Equity, Return On Assets, and Current Ratio

Key metrics snapshot

Return On Equity

-46%

YoY: -35%

Industry median: -42% (n=671)

View history

Return On Assets

-43%

YoY: -33%

Industry median: -47% (n=669)

View history

Current Ratio

10.22x

YoY: -5.1%

Industry median: 3.43x (n=666)

View history

Revenues YoY

-100%

YoY:

Industry median: 5.1% (n=105)

View history

NetIncomeLoss YoY

-66%

YoY:

Industry median: 0.36% (n=639)

View history

Profitability

Metric Latest value YoY change
Return On Equity -46% -35%
Return On Assets -43% -33%

Financial Health

Metric Latest value YoY change
Current Ratio 10.22x -5.1%

Growth

Metric Latest value YoY change
Revenues YoY -100%
NetIncomeLoss YoY -66%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 27,850,833 +37%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%